$108.91
1.040.96%
Last update: 11:29 AM
15 minutes delayed
Comments
Loading...
Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock, Earnings Estimates, EPS, And Revenue
Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS Estimate
$5.520
Quarterly Revenue Estimate
$1B
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$3.9B
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Jazz Pharmaceuticals (JAZZ) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-07-31 | $5.30 | $4.80 | 10.4 % |
| Mar 2024 | 2024-05-01 | $2.68 | $4.18 | -35.9 % |
| Dec 2023 | 2024-02-28 | $5.02 | $5.16 | -2.71 % |
| Sep 2023 | 2023-11-08 | $4.84 | $4.91 | -1.43 % |
Jazz Pharmaceuticals (JAZZ) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-07-31 | $1.02B | $1.01B | 1.39 % |
| Mar 2024 | 2024-05-01 | $901.98M | $953.90M | -5.44 % |
| Dec 2023 | 2024-02-28 | $1.01B | $1.01B | 0.20 % |
| Sep 2023 | 2023-11-08 | $972.14M | $965.73M | 0.66 % |
FAQ
When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?
Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
What were the latest earnings per share (EPS) for Jazz Pharmaceuticals (NASDAQ:JAZZ)?
The Actual EPS was $5.30, which beat the estimate of $4.80.
What were Jazz Pharmaceuticals’s (NASDAQ:JAZZ) revenues?
The Actual Revenue was $1B, which beat the estimate of $1B.
Browse earnings estimates, EPS, and revenue on all stocks.